HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subcellular and molecular mechanisms of the effects of cardiac glycosides and angiotensin-converting enzyme inhibitors on contractile function and energy conversion in myocardial myofibrils under normal conditions and during acute cardiac insufficiency.

Abstract
Experiments on skinned and hybrid myocardial fibers isolated from normal dogs and animals subjected to 120-min occlusion of the anterior interventricular branch of the coronary artery showed that in contrast to cardiac glycosides, angiotensin-converting enzyme inhibitors suppress contractile ability of myocardial myofibrils in a dose-independent manner within the concentration range of 10(-12)-10(-4)M. This effect is accompanied by a decrease in fiber relaxation rate most pronounced in the presence of captopril. Actin, the major protein of fine filaments is the target for b-acetyldigoxin, K-strophanthin, captopril, enalapril, and trandolapril in myocardial myofibrils. During coronary occlusion, the inhibitors of angiotensin-converting enzyme induce structural and conformational changes in actin that decrease efficiency of contraction. The data obtained cast doubt on advisability of therapeutic use of angiotensin-converting enzyme inhibitors in the therapy of myocardial infarction, especially in its early period.
AuthorsG V Sukoyan, V N Karsanov, D R Tatulashvili, E I Gochua, T G Samsonidze, N V Karsanov
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 133 Issue 1 Pg. 74-80 (Jan 2002) ISSN: 0007-4888 [Print] United States
PMID12170313 (Publication Type: Journal Article)
Chemical References
  • Actins
  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiac Glycosides
Topics
  • Actins (chemistry)
  • Acute Disease
  • Angiotensin-Converting Enzyme Inhibitors (pharmacology)
  • Animals
  • Cardiac Glycosides (antagonists & inhibitors)
  • Dogs
  • Energy Metabolism
  • In Vitro Techniques
  • Models, Molecular
  • Myocardial Contraction (drug effects)
  • Myocardial Ischemia (metabolism, physiopathology)
  • Myocardium (metabolism, ultrastructure)
  • Myofibrils (drug effects, metabolism)
  • Protein Conformation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: